Dysregulated STAT3 signaling and T cell immunometabolic dysfunction define a targetable, high mortality subphenotype of critically ill children

• Published in: medRxiv : the preprint server for health sciences
• Main Authors: Lindell, Robert B, Sayed, Samir, Campos, Jose S, Knight, Montana, Mauracher, Andrea A, Hay, Ceire A, Conrey, Peyton E, Fitzgerald, Julie C, Yehya, Nadir, Famularo, Stephen T, Arroyo, Teresa, Tustin, Richard, Fazelinia, Hossein, Behrens, Edward M, Teachey, David T, Freeman, Alexandra F, Bergerson, Jenna R E, Holland, Steven M, Leiding, Jennifer W, Weiss, Scott L, Hall, Mark W, Zuppa, Athena F, Taylor, Deanne M, Feng, Rui, Wherry, E John, Meyer, Nuala J, Henrickson, Sarah E
• Format: Journal Article
• Language: English
• Published: United States 11.06.2024

Sepsis is the leading cause of death of hospitalized children worldwide. Despite the established link between immune dysregulation and mortality in pediatric sepsis, it remains unclear which host immune factors contribute causally to adverse sepsis outcomes. Identifying modifiable pathobiology is an essential first step to successful translation of biologic insights into precision therapeutics. We designed a prospective, longitudinal cohort study of 88 critically ill pediatric patients with multiple organ dysfunction syndrome (MODS), including patients with and without sepsis, to define subphenotypes associated with targetable mechanisms of immune dysregulation. We first assessed plasma proteomic profiles and identified shared features of immune dysregulation in MODS patients with and without sepsis. We then employed consensus clustering to define three subphenotypes based on protein expression at disease onset and identified a strong association between subphenotype and clinical outcome. We next identified differences in immune cell frequency and activation state by MODS subphenotype and determined the association between hyperinflammatory pathway activation and cellular immunophenotype. Using single cell transcriptomics, we demonstrated STAT3 hyperactivation in lymphocytes from the sickest MODS subgroup and then identified an association between STAT3 hyperactivation and T cell immunometabolic dysregulation. Finally, we compared proteomics findings between patients with MODS and patients with inborn errors of immunity that amplify cytokine signaling pathways to further assess the impact of STAT3 hyperactivation in the most severe patients with MODS. Overall, these results identify a potentially pathologic and targetable role for STAT3 hyperactivation in a subset of pediatric patients with MODS who have high severity of illness and poor prognosis.